Send to printer »

Sounds of Science Podcasts: March 09, 2017

Cancer Immunotherapy: CAR T as 'Car Race'

Sounds of Science Podcast

  • Brad Loncar, CEO of Loncar Investments, weighs in on recent developments in the scramble to develop CAR T cancer immunotherapies. How significant a setback is Juno Therapeutics’ halting development of JCAR015? How could some second-tier companies yet come out on top in the “car race”?